Sorrento Therapeutics Inc.

Company Website

6042 Cornerstone Ct. West Ste., B
San Diego, CA 92121

Sourcebook Data

View all the companies in Biomed & Biotech Firms - Publicly Traded*

Sorrento Therapeutics Inc.

Market Cap as of 6/12/2015

$521,121,120

Market Cap as of 7/03/2014

$188,606,718

Market Cap as of 07/02/2013

$100,822,624

Market Cap as of 06/26/2012

$80,966,827

Market Cap as of 01/04/2012

$49,961,930

Market Cap as of 06/20/2011

$74,909,130

Market Cap as of 01/06/2011

$135,050,500

Exchange and Ticker Symbol

OTC US: SRNE

Fields of Research

Focuses on applying its proprietary technology platform for the discovery and development of human therapeutic antibodies for the treatment of various disease conditions, such as cancer, inflammation, metabolic and infectious diseases in the United State

Major Products

STI Technology

Executives

Richard Vincent

  • Chief Financial Officer

Henry Ji

  • Chief Executive Officer

Similar Companies

Aircraft Manufacturing336411
AIRCRAFT3721
Other Aircraft Parts and Auxiliary Equipment Manufacturing336413
AIRCRAFT PARTS AND AUXILIARY EQUIPMENT, NOT ELSEWHERE CLASSIFIED3728
Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)541712
AIRCRAFT3721